A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

Clinical trial NCT06522997 · COMPLETED

Trial details

NCT number: NCT06522997
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2024-08-08
Primary completion: 2025-10-24
Enrollment: 1222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.